Solu
About:
Solu is combating antibiotic resistance by building the most extensive bacterial DNA library
Website: https://www.solu.bio
Twitter/X: solu_bio
Top Investors: Lifeline Ventures, Wave Ventures, Kristian Ranta
Description:
Solu mission to revolutionize the world of bacterial DNA analysis.
Total Funding Amount:
1M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Helsinki, Southern Finland, Finland
Founded Date:
2022-12-01
Contact Email:
sam(AT)solu.bio
Founders:
Kerkko Visuri, Sam Sihvonen
Number of Employees:
1-10
Last Funding Date:
2023-06-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai